Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.58p
   
  • Change Today:
    -0.046p
  • 52 Week High: 19.00
  • 52 Week Low: 6.58
  • Currency: UK Pounds
  • Shares Issued: 226.75m
  • Volume: 4,500
  • Market Cap: £14.92m

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

Key Personnel

CEO: Carolyn Cross
Chairman: Jean Charest
Chief Technology Officer: Nicolas Loebel
Independent Non-Executive Director: Junaid Bajwa
Independent Non-Executive Director: Simon Sinclair
Interim CFO: Kwong Choo
Senior Independent Non-Executive Director: Jean Duvall
Non-Executive Dir: Craig Tooman, Michael Farrar

Contact Details

Address: 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6
Phone: +1 604 669 0555
Website: https://ondinebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: CA68234M2058

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 6.58p
Change Today -0.046p
% Change -0.70 %
52 Week High 19.00
52 Week Low 6.58
Volume 4,500
Shares Issued 226.75m
Market Cap £14.92m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.84% below the market average48.84% below the market average48.84% below the market average48.84% below the market average48.84% below the market average
62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average
Price Trend
86.82% below the market average86.82% below the market average86.82% below the market average86.82% below the market average86.82% below the market average
50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average
Income Not Available
Growth
46.2% below the market average46.2% below the market average46.2% below the market average46.2% below the market average46.2% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average

OBI Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
10:41 4,500 @ 6.70p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page